Table 1
Hepatic and muscular content of TGs (mg/g tissue) in different study groups

Age (Weeks)	Sex	CF1-CD	CF1-HCD	DF1-CD	DF1-HCD
Hepatic TGs content (mg/g tissue)
5	Male	76.4 ± 7	78 ± 8	77 ± 6	79 ± 6
5	Female	74 ± 6	76 ± 5	75 ± 5	76 ± 5
10	Male	81 ± 8	85 ± 8	87 ± 7	91 ± 8*
10	Female	78 ± 5	80 ± 6	81 ± 5***	85 ± 7*
15	Male	84 ± 7	92 ± 9*	96 ± 8*	105 ± 9,*
15	Female	81 ± 5	84 ± 7***	86 ± 7***	92 ± 7,,**
20	Male	86 ± 8	94 ± 8*	98 ± 6*	109 ± 9,*
20	Female	83 ± 6	88 ± 6	92 ± 7*	99 ± 10,,**
25	Male	94 ± 9	99 ± 9	103 ± 9*	111 ± 10,*
25	Female	87 ± 6	94 ± 7	98 ± 6*	104 ± 8,*
30	Male	98 ± 9	104 ± 10	108 ± 9*	116 ± 10,*
30	Female	92 ± 7	96 ± 8	102 ± 8*	110 ± 9,*
Muscular TGs content (mg/g tissue)
5	Male	1.52 ± 0.12	1.53 ± 0.1	1.6 ± 0.11	1.65 ± 0.13,*
5	Female	1.44 ± 0.11	1.5 ± 0.11	1.48 ± 0.12***	1.51 ± 0.12***
10	Male	1.75 ± 0.1	1.9 ± 0.14*	1.84 ± 0.14	2.25 ± 0.17,*
10	Female	1.63 ± 0.13***	1.82 ± 0.13*	1.71 ± 0.13***	1.88 ± 0.12,**
15	Male	1.82 ± 0.12	2.1 ± 0.12*	2.05 ± 0.16*	2.74 ± 0.21,*
15	Female	1.71 ± 0.1***	1.85 ± 0.12,**	1.89 ± 0.17,**	2.2 ± 0.16,,**
20	Male	2 ± 0.11	2.15 ± 0.14*	2.20 ± 0.15*	2.81 ± 0.17,*
20	Female	1.86 ± 0.14***	1.94 ± 0.13***	2.04 ± 0.17,**	2.32 ± 0.21,,**
25	Male	2.1 ± 0.12	2.2 ± 0.15	2.48 ± 0.2,*	2.96 ± 0.23,*
25	Female	1.94 ± 0.13***	2.1 ± 0.12*	2.2 ± 0.16^,**	2.46 ± 0.21,,**
30	Male	1.9 ± 0.1	2.2 ± 0.15*	2.7 ± 0.15,*	3 ± 0.26,*
30	Female	1.85 ± 0.12	1.98 ± 0.11***	2.55 ± 0.18,*	2.78 ± 0.19,,**